Market Segment: Deubiquitination Therapeutics Solution
Linkedin: Stablix LinkedIn Company ProfileEstimated Revenue: $10M
Estimated Employees: 50
Address: 450 East 29th Street, New York NY
Description: Stablix is a biotechnology company that specializes in targeted protein stabilization (TPS) to develop transformative medicines for patients with unmet medical needs. They are pioneers in the field of targeted deubiquitination therapeutics (TDT) and ar...
Business Profile
